Quality of life of the SQ house dust mite sublingual immunotherapy tablet in Italian adolescents with house dust mite-induced allergic rhinitis

被引:0
作者
Catamero, Francesco [1 ,2 ]
Giovannini, Mattia [1 ,2 ]
Barni, Simona [1 ]
Liccioli, Giulia [1 ]
Sarti, Lucrezia [1 ]
Tomei, Leonardo [1 ]
Pessina, Benedetta [1 ,2 ]
Valleriani, Claudia [3 ]
Marzi, Chiara [4 ]
Baccini, Michela [4 ]
Peroni, Diego [5 ]
Mori, Francesca [1 ]
机构
[1] Meyer Childrens Hosp IRCCS, Allergy Unit, Florence, Italy
[2] Univ Florence, Dept Hlth Sci, Florence, Italy
[3] Meyer Childrens Hosp IRCCS, Immunol Lab, Florence, Italy
[4] Univ Florence, Dept Stat, Comp Sci & Applicat G Parenti, Florence, Italy
[5] Univ Pisa, Dept Clin & Expt Med, Sect Pediat, Pisa, Italy
关键词
Allergy; Adolescent; SLIT; Allergen immunotherapy; Quality of life; DISEASES; ASTHMA;
D O I
10.1186/s13052-025-01947-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
House dust mite (HDM) is the most common cause of perennial allergy worldwide, causing allergic rhinitis with or without conjunctivitis (AR/C). HDM-related clinical manifestations can be treated with allergy pharmacotherapy or allergen immunotherapy (AIT) in selected cases. AIT is acknowledged as the only therapeutic approach capable of modifying the course of allergic diseases. SQ HDM-SLIT tablets (Accarizax; Merck & Co, Kenilworth, NJ/ALK-Abell & ograve;, H & oslash;rsholm, Denmark) ensures a constant potency ratio of major HDM allergens of the Dermatophagoides pteronyssinus (DERM_PT) and Dermatophagoides farinae (DERM_FA) HDM species and has demonstrated beneficial effects on allergic rhinoconjunctivitis outcomes. In Italy, rhinoconjunctivitis affects up to as many as 40% of adolescents, but no studies on HDM AIT quality of life (QoL) regarding this exclusive cohort of patients have been specifically conducted. The aim of this study is to evaluate SQ HDM SLIT tablets' performance in improving QoL in Italian adolescents. To assess the treatment at T0, T1, and T2, we employed the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ(s)), a standardized self-administered questionnaire designed for Italian patients aged 12 and above. RQLQ(s) median values at T2 and T1 were significantly lower than those at T0 (p-values equal to 0.0018 and 0.0051 for T0 vs. T2 and T0 vs. T1, respectively). Our findings suggest that the QoL of SQ HDM SLIT tablet is highly promising, demonstrating substantial potential in alleviating signs and symptoms. Our data suggest that QoL significantly improved with SQ-HDM SLIT, highlighting the potential importance of introducing this therapy for selected cases.
引用
收藏
页数:6
相关论文
共 9 条
[1]   Dust mite allergens: ecology and distribution. [J].
Arlian L.G. ;
Morgan M.S. ;
Neal J.S. .
Current Allergy and Asthma Reports, 2002, 2 (5) :401-411
[2]   Allergen immunotherapy: Therapeutic vaccines for allergic diseases - A WHO position paper [J].
Bousquet, J ;
Lockey, R ;
Malling, HJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) :558-562
[3]   Prevalence of self-perceived allergic diseases and risk factors in Italian adolescents [J].
Brescianini, Sonia ;
Brunetto, Barbara ;
Iacovacci, Patrizia ;
D'Ippolito, Cristina ;
Alberti, Giuseppina ;
Schirru, Maria Antonietta ;
Stazi, Maria Antonietta ;
Pini, Carlo ;
Di Felice, Gabriella ;
Barletta, Bianca .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2009, 20 (06) :578-584
[4]   Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial [J].
Demoly, Pascal ;
Emminger, Waltraud ;
Rehm, Dorte ;
Backer, Vibeke ;
Tommerup, Lene ;
Kleine-Tebbe, Joerg .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) :444-+
[5]   Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma:: 10-year follow-up on the PAT study [J].
Jacobsen, L. ;
Niggemann, B. ;
Dreborg, S. ;
Ferdousi, H. A. ;
Halken, S. ;
Host, A. ;
Koivikko, A. ;
Norberg, L. A. ;
Valovirta, E. ;
Wahn, U. ;
Moller, C. .
ALLERGY, 2007, 62 (08) :943-948
[6]   SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms [J].
Mosbech, Holger ;
Canonica, G. Walter ;
Backer, Vibeke ;
de Blay, Frederic ;
Klimek, Ludger ;
Broge, Louise ;
Ljorring, Christian .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (02) :134-U183
[7]   Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial [J].
Nolte, Hendrik ;
Bernstein, David I. ;
Nelson, Harold S. ;
Kleine-Tebbe, Joerg ;
Sussman, Gordon L. ;
Seitzberg, Dorthe ;
Rehm, Dorte ;
Kaur, Amarjot ;
Li, Ziliang ;
Lu, Susan .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (06) :1631-1638
[8]   Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis [J].
Okubo, Kimihiro ;
Masuyama, Keisuke ;
Imai, Toru ;
Okamiya, Kazuhiro ;
Stage, Brian Sonne ;
Seitzberg, Dorthe ;
Konno, Akiyoshi .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (06) :1840-+
[9]   EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis [J].
Roberts, G. ;
Pfaar, O. ;
Akdis, C. A. ;
Ansotegui, I. J. ;
Durham, S. R. ;
van Wijk, R. Gerth ;
Halken, S. ;
Larenas-Linnemann, D. ;
Pawankar, R. ;
Pitsios, C. ;
Sheikh, A. ;
Worm, M. ;
Arasi, S. ;
Calderon, M. A. ;
Cingi, C. ;
Dhami, S. ;
Fauquert, J. L. ;
Hamelmann, E. ;
Hellings, P. ;
Jacobsen, L. ;
Knol, E. F. ;
Lin, S. Y. ;
Maggina, P. ;
Moesges, R. ;
Elberink, J. N. G. Oude ;
Pajno, G. B. ;
Pastorello, E. A. ;
Penagos, M. ;
Rotiroti, G. ;
Schmidt-Weber, C. B. ;
Timmermans, F. ;
Tsilochristou, O. ;
Varga, E. -M. ;
Wilkinson, J. N. ;
Williams, A. ;
Zhang, L. ;
Agache, I. ;
Angier, E. ;
Fernandez-Rivas, M. ;
Jutel, M. ;
Lau, S. ;
van Ree, R. ;
Ryan, D. ;
Sturm, G. J. ;
Muraro, A. .
ALLERGY, 2018, 73 (04) :765-798